Literature DB >> 15076296

Predictive value of maximum urethral closure pressure, urethral hypermobility and urethral incompetence in the diagnosis of clinically significant female genuine stress incontinence.

Erik Schick1, Charles Dupont, Pierre E Bertrand, Martine Jolivet-Tremblay, Jocelyne Tessier.   

Abstract

PURPOSE: We determined the value of urethral hypermobility, maximum urethral closure pressure (MUCP) and urethral incompetence in the diagnosis of stress urinary incontinence (SUI).
MATERIALS AND METHODS: In this study 369 women with clinical symptoms suggestive of SUI without symptoms of bladder overactivity were evaluated in regard to urethral incompetence, urethral hypermobility and mean MUCP. The cohort was divided into 2 groups according to continence/incontinence status. ROC curves were used to test the performance of the various predicting factors. These factors were combined in forward stepwise logistic regression to find the cutoff point that simultaneously optimized sensitivity and specificity.
RESULTS: Continent and incontinent patients differed with regards to urethral incompetence and hypermobility (each p <0.0001). Incontinent patients had a greater probability of a higher grade of each factor. Even after adjusting for the older age of incontinent patients by ANCOVA. MUCP was significantly lower in the incontinent group (p <0.001). The best univariate optimized cutoff point for discriminating continence from incontinence was obtained with urethral incompetence greater than grade I.
CONCLUSIONS: The best single predictor of clinically significant SUI is urethral incompetence, followed by urethral hypermobility and MUCP. When combining several factors, namely grade II urethral incompetence with grade III hypermobility, grade III urethral incompetence with grades I to III hypermobility and grade IV urethral incompetence with or without urethral hypermobility, all indicated more than a 90% probability of clinically significant SUI.

Entities:  

Mesh:

Year:  2004        PMID: 15076296     DOI: 10.1097/01.ju.0000120224.67012.39

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  Incontinence in the elderly, 'normal' ageing, or unaddressed pathology?

Authors:  William Gibson; Adrian Wagg
Journal:  Nat Rev Urol       Date:  2017-04-11       Impact factor: 14.432

2.  Urethral hypermobility after anti-incontinence surgery - a prognostic indicator?

Authors:  Volker Viereck; Hans-Ulrich Pauer; Oda Hesse; Werner Bader; Ralf Tunn; Rainer Lange; Reinhard Hilgers; Günter Emons
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-15

3.  Stress urinary incontinence: relative importance of urethral support and urethral closure pressure.

Authors:  John O L DeLancey; Elisa R Trowbridge; Janis M Miller; Daniel M Morgan; Kenneth Guire; Dee E Fenner; William J Weadock; James A Ashton-Miller
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

4.  Maximum urethral closure pressure in women: normative data and evaluation as a diagnostic test.

Authors:  Dharmesh S Kapoor; Fadi Housami; Paul White; Lucy Swithinbank; Marcus Drake
Journal:  Int Urogynecol J       Date:  2012-05-15       Impact factor: 2.894

Review 5.  The pathophysiology of stress urinary incontinence: a systematic review and meta-analysis.

Authors:  Kobra Falah-Hassani; Joanna Reeves; Rahman Shiri; Duane Hickling; Linda McLean
Journal:  Int Urogynecol J       Date:  2021-01-08       Impact factor: 1.932

Review 6.  Recent advances in urodynamics in women.

Authors:  Georgina Baines; Ana Sofia Da Silva; George Araklitis; Dudley Robinson; Linda Cardozo
Journal:  F1000Res       Date:  2020-06-15

7.  Present value of the Urethral mobility test as a tool to assess Stress urinary incontinence due to Intrinsic sphincteric deficiency.

Authors:  Daniela Robledo; Laura Zuluaga; Alejandra Bravo-Balado; Cristina Domínguez; Carlos Gustavo Trujillo; Juan Ignacio Caicedo; Martín Rondón; Julián Azuero; Mauricio Plata
Journal:  Sci Rep       Date:  2020-12-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.